Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 310
Filtrar
1.
BMJ Case Rep ; 16(7)2023 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-37460246

RESUMEN

We report a previously healthy woman in her 50s who presented with sepsis, rapidly progressive purpuric rash and disseminated intravascular coagulation. She was diagnosed with acute infective purpura fulminans due to invasive pneumococcal infection likely secondary to sinusitis. Our case report discusses our initial diagnostic uncertainty and approach in investigating and treating such a critically unwell patient.


Asunto(s)
Coagulación Intravascular Diseminada , Infecciones Neumocócicas , Púrpura Fulminante , Púrpura , Sinusitis , Femenino , Humanos , Púrpura Fulminante/complicaciones , Streptococcus pneumoniae , Infecciones Neumocócicas/complicaciones , Infecciones Neumocócicas/diagnóstico , Infecciones Neumocócicas/terapia , Coagulación Intravascular Diseminada/complicaciones , Sinusitis/complicaciones
2.
BMJ Case Rep ; 15(5)2022 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-35589268

RESUMEN

Invasive pneumococcal disease occurs in high-risk patient population which includes patients with asplenia and primary hypocomplementaemia. Pneumococcal sepsis can rarely cause disseminated intravascular coagulation (DIC) and intravascular thrombosis of small and medium sized vessels called purpura fulminans which is associated with a high mortality rate. We present the case of an immunocompetent woman in her 50s with an intact spleen who presented with septic shock from Streptococcus pneumoniae bacteraemia. Her hospital course rapidly progressed to multiorgan dysfunction, DIC and purpura fulminans. She was treated aggressively with broad spectrum antibiotics, coagulation factor replacement, multiple vasopressor support, renal replacement therapy and mechanical ventilator support. Despite aggressive measures, she succumbed to the multiorgan failure.


Asunto(s)
Bacteriemia , Coagulación Intravascular Diseminada , Enfermedades del Sistema Inmune , Infecciones Neumocócicas , Púrpura Fulminante , Adulto , Bacteriemia/complicaciones , Coagulación Intravascular Diseminada/complicaciones , Femenino , Humanos , Infecciones Neumocócicas/complicaciones , Infecciones Neumocócicas/terapia , Púrpura Fulminante/complicaciones , Streptococcus pneumoniae
3.
Emerg Microbes Infect ; 10(1): 1369-1377, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34151740

RESUMEN

Few studies on adult pneumococcal septic arthritis are sufficiently large enough to assess both epidemiological trends following routine pneumococcal immunization and clinical disease. With major shifts in serotypes causing invasive pneumococcal disease (IPD), we wanted to determine the clinical phenotype of adult septic arthritis caused by Streptococcus pneumoniae. We conducted a retrospective cohort study of pneumococcal infections in Bristol and Bath, UK, 2006-2018. We defined pneumococcal septic arthritis as adults with clinically-confirmed septic arthritis, with pneumococcus isolated from sterile-site culture or urinary antigen test positivity. Clinical records were reviewed for each patient in the cohort. Septic arthritis accounted for 1.7% of all IPD cases. 45 cases of adult pneumococcal septic arthritis occurred, with disease typically affecting older adults and those with underlying comorbidity. 67% patients had another focus of infection during their illness. 66% patients required increased care on discharge and 43% had reduced range of movement. In-hospital case fatality rate was 6.7%. One-year patient mortality was 31%. Currently most cases of adult pneumococcal septic arthritis are due to non-PCV13 serotypes which are associated with more severe disease. Non-PCV-13 serotypes had higher prevalence of concomitant pneumococcal infection at another site (73.7% versus 36.6%), increased intensive care or high-dependency unit requirement (32.4% versus 0%), and increased inpatient and 1-year case fatality rate (8.8% versus 0%, and 32.4% versus 27.4% respectively) compared to PCV-13 serotypes. Pneumococcal septic arthritis remains a small proportion of IPD. However, there is significant associated morbidity and mortality, and pneumococcal septic arthritis requires monitoring in coming years.


Asunto(s)
Artritis Infecciosa/epidemiología , Artritis Infecciosa/microbiología , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/clasificación , Adulto , Anciano , Anciano de 80 o más Años , Artritis Infecciosa/terapia , Comorbilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infecciones Neumocócicas/terapia , Estudios Retrospectivos , Factores de Riesgo , Serogrupo , Resultado del Tratamiento , Reino Unido/epidemiología , Adulto Joven
4.
BMJ Case Rep ; 14(1)2021 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-33500295

RESUMEN

A 42-year-old woman with a history of acute myeloid leukaemia status postallogeneic stem cell transplant presented with fevers, altered mental status, pulmonary infiltrates and septic shock that further progressed to thrombocytopenia and purpura fulminans. Laboratory studies were consistent with a diagnosis of thrombotic thrombocytopenic purpura (TTP). Blood cultures grew Streptococcus pneumoniae On chart review, our patient had a history of low immunoglobulin levels following stem cell transplant, which may have predisposed her to pneumococcal infection. The patient responded to therapy with ceftriaxone, plasma exchange, rituximab and caplacizumab. This is the fourth-documented case of pneumococcal induced TTP and, to the best of our knowledge, the first-describing pneumococcal induced TTP with purpura fulminans. We conclude that patients with TTP should be evaluated for infectious aetiologies and empiric antibiotics should be considered. Clinicians should be aware of the possibility for TTP to lead to purpura fulminans.


Asunto(s)
Bacteriemia/complicaciones , Infecciones Neumocócicas/complicaciones , Púrpura Trombocitopénica Trombótica/etiología , Choque Séptico/complicaciones , Adulto , Antibacterianos/uso terapéutico , Bacteriemia/sangre , Bacteriemia/terapia , Ceftriaxona/uso terapéutico , Diagnóstico Diferencial , Femenino , Fibrinolíticos/uso terapéutico , Dedos/patología , Dedos/cirugía , Gangrena , Glucocorticoides/uso terapéutico , Enfermedad Injerto contra Huésped/tratamiento farmacológico , Humanos , Factores Inmunológicos/uso terapéutico , Leucemia Mieloide Aguda/terapia , Nariz/patología , Intercambio Plasmático , Infecciones Neumocócicas/sangre , Infecciones Neumocócicas/terapia , Púrpura Fulminante/sangre , Púrpura Fulminante/diagnóstico , Púrpura Trombocitopénica Trombótica/sangre , Púrpura Trombocitopénica Trombótica/terapia , Rituximab/uso terapéutico , Choque Séptico/sangre , Choque Séptico/terapia , Anticuerpos de Dominio Único/uso terapéutico , Trasplante de Células Madre , Dedos del Pie/patología , Dedos del Pie/cirugía
5.
Aging Cell ; 19(10): e13218, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32790148

RESUMEN

The elderly are susceptible to serious infections by Streptococcus pneumoniae (pneumococcus), which calls for a better understanding of the pathways driving the decline in host defense in aging. We previously found that extracellular adenosine (EAD) shaped polymorphonuclear cell (PMN) responses, which are crucial for controlling infection. EAD is produced by CD39 and CD73, and signals via A1, A2A, A2B, and A3 receptors. The objective of this study was to explore the age-driven changes in the EAD pathway and its impact on PMN function. We found in comparison to young mice, PMNs from old mice expressed significantly less CD73, but similar levels of CD39 and adenosine receptors. PMNs from old mice failed to efficiently kill pneumococci ex vivo; however, supplementation with adenosine rescued this defect. Importantly, transfer of PMNs expressing CD73 from young mice reversed the susceptibility of old mice to pneumococcal infection. To identify which adenosine receptor(s) is involved, we used specific agonists and inhibitors. We found that A1 receptor signaling was crucial for PMN function as inhibition or genetic ablation of A1 impaired the ability of PMNs from young mice to kill pneumococci. Importantly, activation of A1 receptors rescued the age-associated defect in PMN function. In exploring mechanisms, we found that PMNs from old mice failed to efficiently kill engulfed pneumococci and that A1 receptor controlled intracellular killing. In summary, targeting the EAD pathway reverses the age-driven decline in PMN antimicrobial function, which has serious implications in combating infections.


Asunto(s)
Adenosina/metabolismo , Neutrófilos/metabolismo , Streptococcus pneumoniae/citología , 5'-Nucleotidasa/biosíntesis , 5'-Nucleotidasa/inmunología , Adenosina/inmunología , Animales , Senescencia Celular/inmunología , Masculino , Ratones , Ratones Endogámicos C57BL , Neutrófilos/enzimología , Neutrófilos/inmunología , Neutrófilos/trasplante , Infecciones Neumocócicas/inmunología , Infecciones Neumocócicas/microbiología , Infecciones Neumocócicas/terapia , Transducción de Señal
6.
Cells ; 9(7)2020 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-32660087

RESUMEN

The nasal priming with nonviable Lactobacillus rhamnosus CRL1505 (NV1505) or its purified peptidoglycan (PG1505) differentially modulates the respiratory innate immune response in infant mice, improving their resistance to primary respiratory syncytial virus (RSV) infection and secondary pneumococcal pneumonia. In association with the protection against RSV-pneumococcal superinfection, it was found that NV1505 or PG1505 significantly enhance the numbers of CD11c+SiglecF+ alveolar macrophages (AMs) producing interferon (IFN)-ß. In this work, we aimed to further advance in the characterization of the beneficial effects of NV1505 and PG1505 in the context of a respiratory superinfection by evaluating whether their immunomodulatory properties are dependent on AM functions. Macrophage depletion experiments and a detailed study of their production of cytokines and antiviral factors clearly demonstrated the key role of this immune cell population in the improvement of both the reduction of pathogens loads and the protection against lung tissue damage induced by the immunobiotic CRL1505 strain. Studies at basal conditions during primary RSV or S. pneumoniae infections, as well as during secondary pneumococcal pneumonia, brought the following five notable findings regarding the immunomodulatory effects of NV1505 and PG1505: (a) AMs play a key role in the beneficial modulation of the respiratory innate immune response and protection against RSV infection, (b) AMs are necessary for improved protection against primary and secondary pneumococcal pneumonia, (c) the generation of activated/trained AMs would be essential for the enhanced protection against respiratory pathogens, (d) other immune and nonimmune cell populations in the respiratory tract may contribute to the protection against bacterial and viral infections, and (e) the immunomodulatory properties of NV1505 and PG1505 are strain-specific. These findings significantly improve our knowledge about the immunological mechanisms involved in the modulation of respiratory immunity induced by beneficial microbes.


Asunto(s)
Factores Inmunológicos/uso terapéutico , Macrófagos Alveolares/inmunología , Peptidoglicano/uso terapéutico , Infecciones Neumocócicas/inmunología , Infecciones por Virus Sincitial Respiratorio/inmunología , Animales , Antígenos CD11/genética , Antígenos CD11/metabolismo , Células Cultivadas , Chlorocebus aethiops , Inmunidad Innata , Factores Inmunológicos/farmacología , Lacticaseibacillus rhamnosus/metabolismo , Macrófagos Alveolares/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Peptidoglicano/farmacología , Infecciones Neumocócicas/terapia , Infecciones por Virus Sincitial Respiratorio/terapia , Lectinas Similares a la Inmunoglobulina de Unión a Ácido Siálico/genética , Lectinas Similares a la Inmunoglobulina de Unión a Ácido Siálico/metabolismo , Células Vero
7.
J Infect Chemother ; 26(7): 715-721, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32334952

RESUMEN

Pneumococcal vaccination has been shown to reduce occurrence of invasive pneumococcal diseases in elderly patients. In this study, we investigated the real-world efficacy of pneumococcal vaccination implemented in elderly individuals in Japan. We reviewed the in-patient database of Juntendo University Hospital and selected elderly patients (≥65 years-old) who had received in-patient care in the general medicine department during 2014-2018. A total of 1355 patients were retrospectively enrolled and comprised of 1045 unvaccinated and 315 vaccinated elderly individuals. Prior vaccination was found associated with all-cause shorter hospital stays (adjusted RR = 0.66, 95% CI = 0.57 to 0.76) and less medical expenditure (adjusted RR = 0.76, 95% CI = 0.66 to 0.87) compared with no vaccination, as well as protection for all-cause in-hospital mortality (adjusted OR = 0.42, 95% CI = 0.22 to 0.83). The association of shorter hospital stays and less medical expenditure with vaccination was also observed in the context of pneumonia, although no altered risk in mortality was observed. In conclusion, this study is one of the first reporting real-world data after the initiation of pneumococcal vaccination program in 2014 in Japan. The national PPV23 vaccination program contributed to the reduction of all-cause in-patient days, mortality, and medical expenses in the elderly aged ≥65 years. Further data is warranted to evaluate the contribution from influenza vaccination and protein-conjugate based pneumococcal vaccine.


Asunto(s)
Programas de Inmunización , Infecciones Neumocócicas/terapia , Vacunas Neumococicas/administración & dosificación , Anciano , Anciano de 80 o más Años , Femenino , Gastos en Salud/estadística & datos numéricos , Mortalidad Hospitalaria , Humanos , Japón/epidemiología , Tiempo de Internación/economía , Tiempo de Internación/estadística & datos numéricos , Masculino , Admisión del Paciente/economía , Admisión del Paciente/estadística & datos numéricos , Infecciones Neumocócicas/economía , Infecciones Neumocócicas/microbiología , Infecciones Neumocócicas/mortalidad , Estudios Retrospectivos , Resultado del Tratamiento
8.
Carbohydr Res ; 489: 107951, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32086019

RESUMEN

α-Glucosyl diacylglycerols (αGlc-DAGs) play an important role in providing protective immunity against Streptococcus pneumoniae infection through the engagement of the Macrophage inducible C-type lectin (Mincle). Herein, we efficiently synthesised αGlc-DAGs containing C12, C14, C16 and C18 acyl chains in 7 steps and 44-47% overall yields, and demonstrated that Mincle signaling was dependent on lipid length using mMincle and hMincle NFAT-GFP reporter cells. The greatest production of GFP in both cell types was elicited by C14 αGlc-DAG. Accordingly, C14 αGlc-DAG has potential to act as an adjuvant to augment the immune response against S. pneumoniae antigens.


Asunto(s)
Glucolípidos/inmunología , Infecciones Neumocócicas/inmunología , Vacunas Neumococicas/inmunología , Streptococcus pneumoniae/inmunología , Vacunas Conjugadas/inmunología , Glucolípidos/síntesis química , Glucolípidos/química , Estructura Molecular , Infecciones Neumocócicas/terapia , Vacunas Neumococicas/síntesis química , Vacunas Neumococicas/química , Vacunas Conjugadas/química
9.
Probiotics Antimicrob Proteins ; 12(2): 494-504, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-31030404

RESUMEN

The effect of Lactobacillus rhamnosus CRL1505 (Lr) on macrophages (Ma) and dendritic cells (DC) in the orchestration of anti-pneumococcal immunity was studied using malnutrition and pneumococcal infection mouse models. Monocytes (Mo), Ma, and DC in two groups of malnourished mice fed with balanced diet (BCD) were studied through flow cytometry; one group was nasally administered with Lr (BCD+Lr group), and the other group was not (BCD group). Well-nourished (WNC) and malnourished (MNC) mice were used as controls.Malnutrition affected the number of respiratory and splenic mononuclear phagocytes. The BCD+Lr treatment, unlike BCD, was able to increase and normalize lung Mo and Ma. The BCD+Lr mice were also able to upregulate the expression of the activation marker MHC II in lung DC and to improve this population showing a more significant effect on CD11b+ DC subpopulation. At post-infection, lung Mo values were higher in BCD+Lr mice than in BCD mice and similar to those obtained in WNC group. Although both repletion treatments showed similar values of lung Ma post-infection, the Ma activation state in BCD+Lr mice was higher than that in BCD mice. Furthermore, BCD+Lr treatment was able to normalize the number and activation of splenic Ma and DC after the challenge.Lr administration stimulates respiratory and systemic mononuclear phagocytes. Stimulation of Ma and DC populations would increase the microbicide activity and improve the adaptive immunity through its antigen-presenting capacity. Thus, Lr contributes to improved outcomes of pneumococcal infection in immunocompromised hosts.


Asunto(s)
Inmunidad , Lacticaseibacillus rhamnosus , Desnutrición/terapia , Infecciones Neumocócicas/terapia , Probióticos/administración & dosificación , Animales , Células Dendríticas/citología , Pulmón/inmunología , Macrófagos/citología , Masculino , Ratones , Infecciones Neumocócicas/inmunología , Bazo/inmunología
10.
Rev Paul Pediatr ; 38: e2018065, 2020.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-31778402

RESUMEN

OBJECTIVE: To describe a case series of four (4) patients with hemolytic uremic syndrome due to Streptococcus pneumoniae in a level four complexity institution in the city of Bogotá, D.C., Colombia. CASES DESCRIPTION: We describe cases of four patients who presented respiratory symptoms and fever. All four patients were in regular conditions on hospital admission, after which they required intensive care and ventilatory support. Upon admission, three cases showed evidence of pleuropulmonary complication. Penicillin-sensitive Streptococcus pneumoniae was isolated in all cases. All patients presented anemia, severe thrombocytopenia, schistocytes on peripheral blood smear, and hyperazotemia. They required blood transfusion and renal replacement therapy during their hospitalization. The patients were diagnosed with hemolytic uremic syndrome due to S. pneumoniae. Three of the four patients had a progressive recovery of the renal function and were discharged after an average of 36 days of hospital stay. The remaining patient had two amputations in the extremities due to thrombotic vascular complications and was discharged after 99 days of hospital stay, requiring hemodialysis every other day. COMMENTS: Hemolytic uremic syndrome due to Streptococcus pneumoniae is a rare but severe complication of invasive pneumococcal disease. Complicated pneumonia is the main condition associated with this entity. It is noteworthy the short period in which these cases were presented, considering the low annual incidence of the disease.


Asunto(s)
Síndrome Hemolítico-Urémico/etiología , Síndrome Hemolítico-Urémico/terapia , Infecciones Neumocócicas/complicaciones , Streptococcus pneumoniae/aislamiento & purificación , Adolescente , Amputación Quirúrgica/métodos , Transfusión Sanguínea/métodos , Preescolar , Síndrome Hemolítico-Urémico/diagnóstico , Humanos , Lactante , Tiempo de Internación/estadística & datos numéricos , Masculino , Infecciones Neumocócicas/diagnóstico por imagen , Infecciones Neumocócicas/microbiología , Infecciones Neumocócicas/terapia , Neumonía Neumocócica/diagnóstico , Insuficiencia Renal/etiología , Insuficiencia Renal/terapia , Terapia de Reemplazo Renal/métodos , Choque Séptico/etiología , Trombosis/cirugía , Resultado del Tratamiento
11.
Artículo en Inglés | LILACS | ID: biblio-1057206

RESUMEN

ABSTRACT Objective: To describe a case series of four (4) patients with hemolytic uremic syndrome due to Streptococcus pneumoniae in a level four complexity institution in the city of Bogotá, D.C., Colombia. Cases description: We describe cases of four patients who presented respiratory symptoms and fever. All four patients were in regular conditions on hospital admission, after which they required intensive care and ventilatory support. Upon admission, three cases showed evidence of pleuropulmonary complication. Penicillin-sensitive Streptococcus pneumoniae was isolated in all cases. All patients presented anemia, severe thrombocytopenia, schistocytes on peripheral blood smear, and hyperazotemia. They required blood transfusion and renal replacement therapy during their hospitalization. The patients were diagnosed with hemolytic uremic syndrome due to S. pneumoniae. Three of the four patients had a progressive recovery of the renal function and were discharged after an average of 36 days of hospital stay. The remaining patient had two amputations in the extremities due to thrombotic vascular complications and was discharged after 99 days of hospital stay, requiring hemodialysis every other day. Comments: Hemolytic uremic syndrome due to Streptococcus pneumoniae is a rare but severe complication of invasive pneumococcal disease. Complicated pneumonia is the main condition associated with this entity. It is noteworthy the short period in which these cases were presented, considering the low annual incidence of the disease.


RESUMO Objetivo: Descrever uma série de casos de quatro pacientes com síndrome hemolítico-urêmica por pneumococo em uma instituição de referência em Bogotá, Colômbia. Descrição dos casos: Descrevemos os casos de quatro pacientes que apresentaram sintomas respiratórios e febre. Todos estavam em estado geral regular à admissão hospitalar e necessitaram de cuidados intensivos e suporte ventilatório. Na admissão, em três dos casos foi evidenciada a complicação pleuropulmonar. Isolamento de Streptococcus pneumoniae sensível à penicilina foi realizado em todos os casos. Os quatro pacientes precisaram de transfusão sanguínea e terapia de reposição renal durante a hospitalização. Nos testes laboratoriais, observou-se anemia, trombocitopenia grave, presença de esquizócitos em esfregaço de sangue periférico e hiperazotemia. Com esse quadro, o diagnóstico foi de síndrome hemolítico-urêmica associada à infecção por S. pneumoniae. Houve recuperação progressiva da função renal em três dos quatro pacientes, que tiveram alta após 36 dias de internação hospitalar, em média. Um paciente teve complicações vasculares trombóticas, resultando em duas amputações nas extremidades, e teve alta após 99 dias de internação, com necessidade de hemodiálise em dias alternados. Comentários: A síndrome hemolítico-urêmica por Streptococcus pneumoniae é uma complicação rara, mas grave, da doença invasiva pneumocócica. A pneumonia complicada é a principal condição associada a essa entidade. Destaca-se o curto período em que esses casos foram apresentados, levando em conta a baixa incidência anual de síndrome hemolítico-urêmica.


Asunto(s)
Humanos , Masculino , Lactante , Preescolar , Adolescente , Infecciones Neumocócicas/complicaciones , Streptococcus pneumoniae/aislamiento & purificación , Síndrome Hemolítico-Urémico/etiología , Síndrome Hemolítico-Urémico/terapia , Infecciones Neumocócicas/microbiología , Infecciones Neumocócicas/terapia , Infecciones Neumocócicas/diagnóstico por imagen , Neumonía Neumocócica/diagnóstico , Choque Séptico/etiología , Trombosis/cirugía , Transfusión Sanguínea/métodos , Resultado del Tratamiento , Terapia de Reemplazo Renal/métodos , Insuficiencia Renal/etiología , Insuficiencia Renal/terapia , Síndrome Hemolítico-Urémico/diagnóstico , Amputación Quirúrgica/métodos , Tiempo de Internación/estadística & datos numéricos
12.
J Foot Ankle Surg ; 58(6): 1293-1297, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31679684

RESUMEN

We report an uncommon case of septic arthritis of the ankle from a Streptococcus pneumoniae infection and provide an update of the literature reported since 2002. A 58-year-old female presented to the hospital with right ankle pain and an inability to bear weight. She reported a history of productive cough, vomiting, diarrhea, and subjective fevers 4 days earlier. Streptococcus pneumonia was identified in her ankle aspirate, and she was treated urgently with operative incision and debridement, followed by postoperative intravenous antibiotics. At her 7-week follow-up, she demonstrated complete resolution of symptoms and near-complete recovery of range of motion. This case demonstrates the importance of early identification, as the majority of patients recover fully with prompt treatment. The literature review included 44 cases of pneumococcal septic arthritis and found that the knee was the most commonly affected joint, followed by the shoulder and ankle. Blood cultures were positive for S. pneumoniae in 27 of 38 adults (71%) and 4 of 6 children (67%). Comorbid conditions were present in 32 of 38 adults (84%) and 4 of 7 children (57%), the most frequent of which were alcoholism and osteoarthritis in adults and malignancy or immunosuppression in children. Additionally, roughly half of included adults had an extra-articular focus of pneumococcal disease, most frequently pneumonia. Operative treatment was undertaken in 32 of 38 adults (84%) and all 7 children. Of adults with data available, 24 of 33 (73%) recovered with complete joint function, compared with 5 of 7 children (71%).


Asunto(s)
Artritis Infecciosa/terapia , Infecciones Neumocócicas/diagnóstico , Antibacterianos/uso terapéutico , Artritis Infecciosa/microbiología , Tos/microbiología , Desbridamiento , Diarrea/microbiología , Femenino , Fiebre/microbiología , Humanos , Persona de Mediana Edad , Infecciones Neumocócicas/terapia , Streptococcus pneumoniae
15.
Br Med Bull ; 131(1): 57-70, 2019 09 19.
Artículo en Inglés | MEDLINE | ID: mdl-31556944

RESUMEN

BACKGROUND: Acute bacterial meningitis (ABM) in adults is associated with a mortality that may exceed 30%. Immunization programs have reduced the global burden; in the UK, declining incidence but persistently high mortality and morbidity mean that clinicians must remain vigilant. SOURCES OF DATA: A systematic electronic literature search of PubMed was performed to identify all ABM literature published within the past 5 years. AREAS OF AGREEMENT AND CONTROVERSY: Clinical features cannot reliably distinguish between ABM and other important infectious and non-infectious aetiologies. Prompt investigation and empirical treatment are imperative. Lumbar puncture (LP) and cerebrospinal fluid microscopy, biochemistry and culture remain the mainstay of diagnosis, but molecular techniques are increasingly useful. The 2016 UK joint specialist societies' guideline provides expert recommendations for the management of ABM, yet published data suggest clinical care delivered in the UK is frequently not adherent. Anxiety regarding risk of cerebral herniation following LP, unnecessary neuroimaging, underutilization of molecular diagnostics and suboptimal uptake of adjunctive corticosteroids compromise management. GROWING POINTS: There is increasing recognition that current antibiotic regimens and adjunctive therapies alone are insufficient to reduce the mortality and morbidity associated with ABM. AREAS TIMELY FOR DEVELOPING RESEARCH: Research should be focused on optimization of vaccines (e.g. pneumococcal conjugate vaccines with extended serotype coverage), targeting groups at risk for disease and reservoirs for transmission; improving adherence to management guidelines; development of new faster, more accurate diagnostic platforms (e.g. novel point-of-care molecular diagnostics); and development of new adjunctive therapies (aimed at the host-inflammatory response and bacterial virulence factors).


Asunto(s)
Infecciones Comunitarias Adquiridas/prevención & control , Meningitis Bacterianas/prevención & control , Adyuvantes Farmacéuticos/uso terapéutico , Corticoesteroides/uso terapéutico , Adulto , Profilaxis Antibiótica , Anticuerpos/uso terapéutico , Técnicas Bacteriológicas , Líquido Cefalorraquídeo/microbiología , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/terapia , Quimioterapia Combinada , Humanos , Meningitis Bacterianas/epidemiología , Meningitis Bacterianas/terapia , Meningitis Meningocócica/epidemiología , Meningitis Meningocócica/prevención & control , Meningitis Meningocócica/terapia , Neisseria meningitidis , Neuroimagen/métodos , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/prevención & control , Infecciones Neumocócicas/terapia , Manejo de Especímenes , Punción Espinal , Reino Unido/epidemiología
16.
J Med Microbiol ; 68(10): 1466-1470, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31389781

RESUMEN

Introduction. Streptococcus pneumoniae and Haemophilus influenzae are both commensals of the human nasopharynx with a high capacity to cause upper and lower respiratory tract infections.Aim. Molecular testing of nasopharyngeal samples from children at the primary care paediatric department presenting with acute respiratory tract infections (ARTIs).Methodology. From June 2016 to May 2017, 156 nasopharyngeal swabs from children diagnosed with ARTIs who had been admitted to or followed up as outpatients at the Department of Paediatrics, SANADOR Hospital (Bucharest, Romania) were tested for the presence of S. pneumoniae, H. influenzae, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, Bordetella pertussis and Bordetella parapertussis DNA.Results. S. pneumoniae had the highest detection rate (53.8 %, n=84/156), followed by H. influenzae (41 %, n=64/156) and S. pneumoniae/H. influenzae co-detection (26.2 %, n=41/156).Conclusion. A definitive laboratory diagnosis of these micro-organisms can be made for invasive disease, but there are difficulties in establishing the aetiology for mucosal infection. Molecular detection tests could complement culture-based tests by strengthening their surveillance.


Asunto(s)
Infecciones por Haemophilus/microbiología , Haemophilus influenzae/aislamiento & purificación , Nasofaringe/microbiología , Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/aislamiento & purificación , Enfermedad Aguda/terapia , Adolescente , Niño , Preescolar , Femenino , Infecciones por Haemophilus/diagnóstico , Infecciones por Haemophilus/terapia , Haemophilus influenzae/genética , Hospitales/estadística & datos numéricos , Humanos , Lactante , Masculino , Infecciones Neumocócicas/diagnóstico , Infecciones Neumocócicas/terapia , Rumanía , Streptococcus pneumoniae/genética
17.
J Infect Chemother ; 25(10): 750-757, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31235348

RESUMEN

The prevalence of nonencapsulated Streptococcus pneumoniae (NESp) has increased with the introduction of pneumococcal conjugate vaccines in children; however, the bacteriological characteristics of NESp have not been sufficiently clarified. In this study, NESp strains isolated from the nasopharyngeal carriage of children from four nursery schools in Japan were analyzed for molecular type, antibiotic susceptibility, and biofilm productivity. A total of 152 putative S. pneumoniae strains were identified by optochin-susceptibility analysis, of which 21 were not serotypeable by slide agglutination, quellung reaction, or multiplex PCR. Among these 21 strains, three were lytA-negative and, therefore, not S. pneumoniae. The remaining 18 strains were positive for lytA, ply, pspK, and bile solubility and were confirmed as NESp. Therefore, the isolation rate of NESp in the S. pneumoniae strains in this study was 12.0% (18/149). Molecular-typing analyses classified five strains as two existing sequence types (STs; ST7502 and ST7786), and 13 strains formed four novel STs. Horizontal spread was suspected, because strains with the same ST were often isolated from the same nursery school. The NESp isolates were generally susceptible to most antimicrobials, with the exception of macrolides; however, all isolates possessed more than one abnormal penicillin-binding protein gene. Furthermore, NESp strains were more effective than encapsulated counterparts at forming biofilms, which showed obvious differences in morphology. These data indicated that NESp strains should be continuously monitored as emerging respiratory pathogens.


Asunto(s)
Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Infecciones Neumocócicas/terapia , Vacunas Neumococicas/uso terapéutico , Streptococcus pneumoniae/aislamiento & purificación , Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana/genética , Humanos , Lactante , Recién Nacido , Japón/epidemiología , Pruebas de Sensibilidad Microbiana , Tipificación Molecular/métodos , Mutación , Mucosa Nasal/microbiología , Proteínas de Unión a las Penicilinas/genética , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/microbiología , Prevalencia , Serotipificación , Streptococcus pneumoniae/genética , Streptococcus pneumoniae/inmunología , Factores de Virulencia/genética
18.
Benef Microbes ; 10(5): 533-541, 2019 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-30964327

RESUMEN

Streptococcus pneumoniae is able to activate coagulation and induce platelet aggregation, both of which are typical responses to systemic inflammation. The interactions between inflammation and coagulation and between soluble adhesion molecules and endothelial cells are important in the pathogenesis of an unbalanced haemostatic system. Therefore, an exaggerated and/or insufficiently controlled haemostatic activity may appreciably contribute to the severity of the disease. The aim of the present study was to evaluate the effect of the oral administration of Lactobacillus casei CRL 431 on platelet and endothelial activation mechanisms in a respiratory pneumococcal infection model in mice. S. pneumoniae induced an increase in platelet counts and enhanced the expression of P-selectin in control group, with higher endothelial activation in lung shown by the increase in von Willebrand factor (vWF) and vascular cell adhesion molecule 1 (VCAM-1) expression. Also, infection induced a decrease in CXCR-4 leukocytes, increased expression in annexinV and cell death at the pulmonary level and decreased antithrombin levels in bronchoalveolar lavage. In contrast, L. casei mice restored platelet counts, favoured faster P-selectin expression, lower vWF levels and VCAM-1 expression than control group. Also, L. casei induced higher levels of annexinV expression and lower cell death in the lung. Moreover, it was able to modulate antithrombin levels within the normal range, which would indicate lower coagulation activation and a protective effect locally exerted by L. casei. In this work, the ability of L. casei to favourably modulate platelet and endothelial functionality during a pulmonary infection with S. pneumoniae was demonstrated. Our findings offer a promising perspective for the use of this probiotic strain in the prevention of thrombotic complications associated with pneumococcal pneumonia, especially in at-risk patients. In addition, the use of L. casei would provide novel alternatives for the prevention and treatment of thrombosis associated with various diseases.


Asunto(s)
Plaquetas/fisiología , Células Endoteliales/fisiología , Lacticaseibacillus casei/crecimiento & desarrollo , Infecciones Neumocócicas/terapia , Probióticos/administración & dosificación , Infecciones del Sistema Respiratorio/terapia , Animales , Análisis Químico de la Sangre , Modelos Animales de Enfermedad , Ratones , Recuento de Plaquetas , Infecciones Neumocócicas/patología , Infecciones del Sistema Respiratorio/patología , Resultado del Tratamiento
19.
Semin Ophthalmol ; 34(2): 115-123, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30879381

RESUMEN

AIMS: To review the clinical profile and report the microbiology and treatment outcomes of endophthalmitis following suture removal. METHODS: In this multi-center, retrospective interventional case series, 11 eyes of 11 patients who developed endophthalmitis following suture removal from January 2006 to December 2017 were reviewed. RESULTS: Nine of the 11 patients developed a culture-proven, acute onset endophthalmitis [5.3 ± 3.1 days (range 2-10 days)]. Mean age was 15.8 ± 21.2 years (median 7; range, 1-66 years). Presenting visual acuity was extremely low ranging from light perception (PL) to counting fingers close to face (CFCF) at the time of diagnosis of endophthalmitis. Out of the 11 patients, 8 belonged to the pediatric age group; four out of those eight had loose sutures secondary to cataract surgery, two patients had loose sutures secondary to penetrating keratoplasty and 1 case each had loose sutures secondary to corneal tear repair and secondary IOL implantation, respectively. Streptococcus pneumoniae was the most common organism and was identified in seven cases and was susceptible to vancomycin in all these cases. Other bacterial isolates were Haemophilus influenzae and Achromobacter denitrificans. Three out of the 11 eyes had visual outcome of 20/200 or better. Six eyes were phthisical and one eye was eviscerated. Mean follow-up was 26.3 ± 31.2 weeks (range 2-92 weeks). Visual outcomes ranged from 20/40 to no light perception at the last follow-up. CONCLUSIONS: Endophthalmitis following suture removal though rare, is observed most commonly in the pediatric population and has an acute and a fulminant course. Streptococcus pneumoniae was the most commonly isolated microorganism. Visual acuity outcomes were poor despite prompt recognition of endophthalmitis and appropriate antibiotic therapy.


Asunto(s)
Remoción de Dispositivos/efectos adversos , Endoftalmitis/etiología , Infecciones Bacterianas del Ojo/etiología , Infecciones Neumocócicas/etiología , Streptococcus pneumoniae/aislamiento & purificación , Infección de la Herida Quirúrgica/etiología , Suturas , Adolescente , Adulto , Anciano , Antibacterianos/uso terapéutico , Niño , Preescolar , Endoftalmitis/microbiología , Endoftalmitis/terapia , Infecciones Bacterianas del Ojo/microbiología , Infecciones Bacterianas del Ojo/terapia , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Infecciones Neumocócicas/microbiología , Infecciones Neumocócicas/terapia , Estudios Retrospectivos , Infección de la Herida Quirúrgica/microbiología , Infección de la Herida Quirúrgica/terapia , Vitrectomía , Adulto Joven
20.
Am J Emerg Med ; 37(5): 1006.e5-1006.e7, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30777376

RESUMEN

BACKGROUND: Purulent bacterial pericarditis is a rare and potentially fatal disease. The course may be fulminant, and the presentation may pose a diagnostic challenge. CASE REPORT: An otherwise healthy 75-year-old male was brought to the emergency department in a state of general deterioration, confusion, and shock. Bedside ultrasound showed a significant pericardial effusion. His condition quickly deteriorated and the resuscitation included emergent bedside pericardiocentesis. The drainage was purulent and later cultures grew out Streptococcus pneumoniae. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Purulent pericarditis is extremely rare but should be considered in the patient with a fulminant infectious process (particularly pneumonia) and signs of pericardial effusion. Treatment should include appropriate antibiotics and early drainage.


Asunto(s)
Pericarditis/diagnóstico , Neumonía Neumocócica/diagnóstico , Sepsis/diagnóstico , Anciano , Reanimación Cardiopulmonar , Drenaje , Resultado Fatal , Humanos , Masculino , Pericardiocentesis , Pericarditis/etiología , Pericarditis/terapia , Infecciones Neumocócicas/diagnóstico , Infecciones Neumocócicas/etiología , Infecciones Neumocócicas/terapia , Neumonía Neumocócica/complicaciones , Neumonía Neumocócica/terapia , Sistemas de Atención de Punto , Sepsis/terapia , Tomografía Computarizada por Rayos X , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...